Skip to content

Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study.

Randomized controlled trial · Nutrients · 2025. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 40005019

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study.

Jung SJ, Cho K, Jung ES et al.
Nutrients · 2025

PubMed ID
40005019
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.